Han Biomedical (ROCO:6999) Total Equity: NT$260.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6999 Han Biomedical Inc ROCO:6999
26 GF Score
Price NT$29.50
! 1 Warning Sign
View Full Analysis

What is Han Biomedical Total Equity?

Han Biomedical ROCO:6999 -1.67% 26 Total Equity is NT$260.1 Mil as of Dec. 2025. GuruFocus rates ROCO:6999 with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Han Biomedical's total equity for the quarter that ended in Dec. 2025 was NT$260.1 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Han Biomedical Total Equity Historical Data

* Premium members only.

The historical data trend for Han Biomedical's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Han Biomedical Total Equity Chart

Han Biomedical Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
161.40 185.91 207.49 249.13 260.10

Han Biomedical Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial 207.49 235.24 249.13 247.66 260.10
ROCO:6999
26GF Score
Han Biomedical Inc ROCO:6999
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Han Biomedical Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Han Biomedical's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=303.067-42.966
=260.1

Han Biomedical's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=303.067-42.966
=260.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$260.1 Mil mean?
Han Biomedical (ROCO:6999) has a Total Equity of NT$260.1 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Han Biomedical and its competitors.
Is Han Biomedical's Total Equity too high?
Han Biomedical's current Total Equity is NT$260.1 Mil. Overall, Han Biomedical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's Total Equity compare to VRTX and REGN?
Han Biomedical's Total Equity of NT$260.1 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Han Biomedical and its competitors. Han Biomedical's current Total Equity is NT$260.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current Total Equity of NT$260.1 Mil. The current Total Equity is NT$260.1 Mil. Han Biomedical's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current Total Equity is NT$260.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Han Biomedical Business Description

Address Xintai 5th Road, 15F-11, No.99, Sec.1, Xizhi District, New Taipei City, TWN
Han Biomedical Inc operates as a bio-material technology platform for the tissue repair market.
26GF Score

Get the complete analysis for ROCO:6999

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$29.50
Price